Baxter International Inc (NYSE:BAX)
$ 21.98 -0.88 (-3.85%) Market Cap: 11.35 Bil Enterprise Value: 18.99 Bil PE Ratio: 0 PB Ratio: 1.88 GF Score: 58/100

Baxter International Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 10:15PM GMT
Release Date Price: $20.15 (-4.37%)
Robert Marcus
JPMorgan Chase & Co - Analyst

Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to have Baxter as our next company presenting. Andrew Hider, the new CEO, first-time presenter at JPMorgan.

We'll do a presentation followed by some Q&A.

Andrew Hider
Baxter International Inc - Chief Executive Officer

Great. Good afternoon, a little silent. Andrew Hider, CEO of Baxter. And I've been here a whopping five months. A little bit about me, I started my career at General Electric. I was there for six years. Then I went to Danaher Corporation.

That was a Danaher for 10. Ran four companies for them anywhere from semiconductor to x-ray to fraction, underground tank storage, as well as instrumentation for dairy food, beverage, and biopharma. Took over a business private company, and then I ran ATS Corporation for almost nine years as the CEO.

I tell you that as a framework, because I view an operating system and continuous improvement at the core of everything we do. And why I was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot